Literature DB >> 30401868

A stratified approach to tuberculosis treatment.

Gavin J Churchyard1,2,3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30401868     DOI： 10.1038/s41591-018-0244-y

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  6 in total

Review 1.  Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape.

Authors:  Patrick P J Phillips; Carole D Mitnick; James D Neaton; Payam Nahid; Christian Lienhardt; Andrew J Nunn
Journal:  PLoS Med       Date:  2019-03-22       Impact factor: 11.069

2.  Should treatment of low-level rifampicin mono-resistant tuberculosis be different?

Authors:  F A Gopie; E Commiesie; S Baldi; M Kamst; D Kaur; W C M de Lange; P S Pinas; D Stijnberg; M Wongsokarijo; C W R Zijlmans; R de Zwaan; D van Soolingen; S G S Vreden; G de Vries
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-01-29

Review 3.  Recent Insights into the Structure and Function of Mycobacterial Membrane Proteins Facilitated by Cryo-EM.

Authors:  Ameya D Bendre; Peter J Peters; Janesh Kumar
Journal:  J Membr Biol       Date:  2021-05-05       Impact factor: 1.843

4.  Predictors of unfavorable responses to therapy in rifampicin-sensitive pulmonary tuberculosis using an integrated approach of radiological presentation and sputum mycobacterial burden.

Authors:  Narendran Gopalan; Vignes Anand Srinivasalu; Ponnuraja Chinnayan; Banurekha Velayutham; Adhin Bhaskar; Ramesh Santhanakrishnan; Thirumaran Senguttuvan; Sridhar Rathinam; Mahilmaran Ayyamperumal; Kumar Satagopan; Dhanalakshmi Rajendran; Tamizhselvan Manoharan; Sekar Lakshmanan; Paulkumaran Paramasivam; Dhanalakshmi Angamuthu; Mangalambal Ganesan; John Washington Easudoss Arockia; Ramesh Babu Venkatesan; Venkatesan Lakshmipathy; Shivakumar Shanmugham; Balaji Subramanyam; Shakila Shankar; Jawahar Mohideen Shaheed; Baskaran Dhanaraj; Narayanan Paranji Ramiyengar; Soumya Swaminathan; Padmapriyadarsini Chandrasekaran
Journal:  PLoS One       Date:  2021-09-20       Impact factor: 3.240

5.  Predictors of slow clinical response and extended treatment in patients with extra-pulmonary tuberculosis in Pakistan, A hospital-based prospective study.

Authors:  Atiqa Ambreen; Sabira Tahseen; Ahmad Wali; Muhammad Jamil; Syed Zeeshan Haider Naqvi; Nauman Safdar; Tehmina Mustafa
Journal:  PLoS One       Date:  2021-11-12       Impact factor: 3.240

Review 6.  A systematic review of endpoint definitions in late phase pulmonary tuberculosis therapeutic trials.

Authors:  N K Hills; J Lyimo; P Nahid; R M Savic; C Lienhardt; P P J Phillips
Journal:  Trials       Date:  2021-08-03       Impact factor: 2.279
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.